Hoa, Nguyen Thi Nhu, et al. “Initial Results of Osimertinib As the First Line Therapy of Advanced EGFR - Mutated Non - Small Cell Lung Cancer”. Journal of Clinical Medicine Hue Central Hospital, vol. 15, no. 91, Dec. 2024, pp. 70-75, doi:10.38103/jcmhch.91.12.